Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-003697-17

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

- To evaluate the efficacy of guselkumab in subjects with active PsA by assessing the reduction in signs and symptoms of PsA. - To assess the safety and tolerability of guselkumab in subjects with active PsA.


Critère d'inclusion

  • Active Psoriatic Arthritis